These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11459123)

  • 1. Possible roles of cardiac chymase after myocardial infarction in hamster hearts.
    Jin D; Takai S; Yamada M; Sakaguchi M; Yao Y; Miyazaki M
    Jpn J Pharmacol; 2001 Jun; 86(2):203-14. PubMed ID: 11459123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of cardiac chymase inhibition during the acute phase of myocardial infarction.
    Jin D; Takai S; Yamada M; Sakaguchi M; Miyazaki M
    Life Sci; 2002 Jun; 71(4):437-46. PubMed ID: 12044843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chymase inhibitor on cardiac function and survival after myocardial infarction.
    Jin D; Takai S; Yamada M; Sakaguchi M; Kamoshita K; Ishida K; Sukenaga Y; Miyazaki M
    Cardiovasc Res; 2003 Nov; 60(2):413-20. PubMed ID: 14613871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent expression of chymase and angiotensin converting enzyme in the hamster heart under pressure overload.
    Li P; Chen PM; Wang SW; Chen LY
    Hypertens Res; 2002 Sep; 25(5):757-62. PubMed ID: 12452330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure.
    Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY
    Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Angiotensin II Type 1 receptor blocker on cardiac angiotensin-converting enzyme and chymase-like activities, and cardiac fibrosis in cardiomyopathic hamsters.
    Shimizu M; Tanaka R; Uchida M; Orito K; Shimamura S; Yamane Y
    J Vet Med Sci; 2006 Mar; 68(3):227-33. PubMed ID: 16598165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chymase inhibitor improves survival in hamsters with myocardial infarction.
    Hoshino F; Urata H; Inoue Y; Saito Y; Yahiro E; Ideishi M; Arakawa K; Saku K
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S11-8. PubMed ID: 12688390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased angiotensin-converting enzyme activity in the left ventricle after infarction.
    Busatto VC; Cicilini MA; Mill JG
    Braz J Med Biol Res; 1997 May; 30(5):679-87. PubMed ID: 9283639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High cardiac angiotensin-II-forming activity in infarcted and non-infarcted human myocardium.
    Ihara M; Urata H; Shirai K; Ideishi M; Hoshino F; Suzumiya J; Kikuchi M; Arakawa K
    Cardiology; 2000; 94(4):247-53. PubMed ID: 11326146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats.
    Kanemitsu H; Takai S; Tsuneyoshi H; Nishina T; Yoshikawa K; Miyazaki M; Ikeda T; Komeda M
    Hypertens Res; 2006 Jan; 29(1):57-64. PubMed ID: 16715654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an angiotensin II receptor antagonist, candesartan cilexetil, on canine intima hyperplasia after balloon injury.
    Miyazaki M; Wada T; Shiota N; Takai S
    J Hum Hypertens; 1999 Jan; 13 Suppl 1():S21-5; discussion S33-4. PubMed ID: 10076917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of vascular angiotensin converting enzyme and chymase in two-kidney, one clip hypertensive hamsters.
    Jin D; Takai S; Shiota N; Miyazaki M
    J Hypertens; 1998 May; 16(5):657-64. PubMed ID: 9797177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac remodeling and angiotensin II-forming enzyme activity of the left ventricle in hamsters with chronic pressure overload induced by ascending aortic stenosis.
    Shimizu M; Tanaka R; Fukuyama T; Aoki R; Orito K; Yamane Y
    J Vet Med Sci; 2006 Mar; 68(3):271-6. PubMed ID: 16598172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of angiotensin-converting enzyme inhibition in adriamycin-induced cardiomyopathy in hamsters.
    Okumura K; Jin D; Takai S; Miyazaki M
    Jpn J Pharmacol; 2002 Feb; 88(2):183-8. PubMed ID: 11928719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue angiotensin II system in the human heart.
    Urata H; Hoffmann S; Ganten D
    Eur Heart J; 1994 Dec; 15 Suppl D():68-78. PubMed ID: 7713117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents.
    Wei CC; Hase N; Inoue Y; Bradley EW; Yahiro E; Li M; Naqvi N; Powell PC; Shi K; Takahashi Y; Saku K; Urata H; Dell'italia LJ; Husain A
    J Clin Invest; 2010 Apr; 120(4):1229-39. PubMed ID: 20335663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart.
    Shiota N; Fukamizu A; Takai S; Okunishi H; Murakami K; Miyazaki M
    J Hypertens; 1997 Apr; 15(4):431-40. PubMed ID: 9211178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
    Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
    Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antiarrhythmic effect of a chymase inhibitor after myocardial infarction.
    Jin D; Takai S; Sakaguchi M; Okamoto Y; Muramatsu M; Miyazaki M
    J Pharmacol Exp Ther; 2004 May; 309(2):490-7. PubMed ID: 14730006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.